Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
4,094,667
-
Share change
-
-335,295
-
Total reported value
-
$6,102,781
-
Put/Call ratio
-
13%
-
Price per share
-
$1.49
-
Number of holders
-
26
-
Value change
-
-$618,015
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2024
As of 30 Sep 2024,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,094,667 shares.
The largest 10 holders included
AIGH Capital Management LLC, Bleichroeder LP, Cable Car Capital LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Royal Bank of Canada, TOCQUEVILLE ASSET MANAGEMENT L.P., STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.